First Horizon Advisors Inc. Buys 760 Shares of Doximity, Inc. (NASDAQ:DOCS)

First Horizon Advisors Inc. boosted its stake in Doximity, Inc. (NASDAQ:DOCS) by 80.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,710 shares of the company’s stock after acquiring an additional 760 shares during the period. First Horizon Advisors Inc.’s holdings in Doximity were worth $48,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. LRI Investments LLC bought a new position in shares of Doximity during the 1st quarter worth approximately $27,000. Blue Trust Inc. boosted its holdings in shares of Doximity by 621.4% during the 2nd quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock worth $37,000 after buying an additional 1,193 shares in the last quarter. GAMMA Investing LLC bought a new position in shares of Doximity during the 4th quarter worth approximately $40,000. DekaBank Deutsche Girozentrale bought a new position in shares of Doximity during the 1st quarter worth approximately $46,000. Finally, Essex Investment Management Co. LLC bought a new position in shares of Doximity during the 1st quarter worth approximately $73,000. 87.19% of the stock is currently owned by institutional investors.

Insider Transactions at Doximity

In other news, CFO Anna Bryson sold 30,000 shares of Doximity stock in a transaction on Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the sale, the chief financial officer now directly owns 309,627 shares in the company, valued at approximately $10,836,945. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Watkin Phoebe L. Yang sold 1,011 shares of Doximity stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the completion of the sale, the director now owns 11,258 shares of the company’s stock, valued at approximately $287,529.32. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Anna Bryson sold 30,000 shares of Doximity stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the completion of the sale, the chief financial officer now directly owns 309,627 shares of the company’s stock, valued at approximately $10,836,945. The disclosure for this sale can be found here. Insiders have sold 77,951 shares of company stock worth $2,471,018 in the last ninety days. Company insiders own 39.40% of the company’s stock.

Analyst Ratings Changes

DOCS has been the subject of several research reports. Wells Fargo & Company downgraded shares of Doximity from an “equal weight” rating to an “underweight” rating and reduced their price target for the company from $27.00 to $19.00 in a research report on Thursday, July 18th. Canaccord Genuity Group lifted their price target on shares of Doximity from $37.00 to $40.00 and gave the company a “buy” rating in a research report on Tuesday. Truist Financial reissued a “hold” rating and issued a $35.00 price target (up previously from $31.00) on shares of Doximity in a research report on Wednesday, August 14th. JPMorgan Chase & Co. lifted their price target on shares of Doximity from $27.00 to $30.00 and gave the company a “neutral” rating in a research report on Monday. Finally, Evercore ISI lifted their price target on shares of Doximity from $29.00 to $34.00 and gave the company an “in-line” rating in a research report on Friday, August 9th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $31.27.

Doximity Price Performance

NASDAQ DOCS opened at $36.43 on Thursday. The stock has a market capitalization of $6.76 billion, a price-to-earnings ratio of 50.60, a PEG ratio of 5.12 and a beta of 1.22. Doximity, Inc. has a one year low of $19.71 and a one year high of $37.25. The business’s fifty day moving average is $29.08 and its 200-day moving average is $27.73.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.